Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Devlin

Showing results (701-710 of 803) with videos related to

Pageof 81
Sort By:
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 6, 2024
Ketogenic diet registry for epilepsy: A cross-sectional feasibility studyElizabeth G Neal, Victoria J Whiteley, Elles van der Louw, et al.
Blood Cancer Discovery|November 15, 2021
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell TherapyRoni Tamari, Ioannis Politikos, David A Knorr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2015
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased RelapseRoni Tamari, Stephen S Chung, Esperanza B Papadopoulos, et al.
Blood|December 3, 2020
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumorsAndrew Dunbar, Kelly L Bolton, Sean M Devlin, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostatePhillip M Devlin, Christina R Brus, Julia Kazakin, et al.
Blood Cancer Journal|August 8, 2020
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphomaKitsada Wudhikarn, M Lia Palomba, Martina Pennisi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood TransplantationStephen Harnicar, Doris M Ponce, Patrick Hilden, et al.
Bone Marrow Transplantation|November 18, 2025
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impactMagdalena Corona, Samantha Brown, Kai Rejeski, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 19, 2016
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of ResultsGil Y Melmed, Peter M Irving, Jennifer Jones, et al.
Pageof 81

Showing results (701-710 of 803) with videos related to

Sort By:
Pageof 81
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|November 6, 2024
Ketogenic diet registry for epilepsy: A cross-sectional feasibility studyElizabeth G Neal, Victoria J Whiteley, Elles van der Louw, et al.
Blood Cancer Discovery|November 15, 2021
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell TherapyRoni Tamari, Ioannis Politikos, David A Knorr, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2015
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased RelapseRoni Tamari, Stephen S Chung, Esperanza B Papadopoulos, et al.
Blood|December 3, 2020
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumorsAndrew Dunbar, Kelly L Bolton, Sean M Devlin, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostatePhillip M Devlin, Christina R Brus, Julia Kazakin, et al.
Blood Cancer Journal|August 8, 2020
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphomaKitsada Wudhikarn, M Lia Palomba, Martina Pennisi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood TransplantationStephen Harnicar, Doris M Ponce, Patrick Hilden, et al.
Bone Marrow Transplantation|November 18, 2025
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impactMagdalena Corona, Samantha Brown, Kai Rejeski, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 19, 2016
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of ResultsGil Y Melmed, Peter M Irving, Jennifer Jones, et al.
Pageof 81